Stryker recasts prior periods after reorganizing to create Ortho Tech, maintains two reportable segments

Stryker recast prior-period segment reporting after creating a new Ortho Tech business to combine orthopaedic instruments with Mako and enabling technologies.Key Highlights:Original SEC Filing: STRYKER CORP [ SYK ] - 8-K - Jun. 26, 2026This is an AI-powered summary. It may contain inaccuracies. Con…

Stryker recast prior-period segment reporting after creating a new Ortho Tech business to combine orthopaedic instruments with Mako and enabling technologies.

Key Highlights:

The company reorganized in Q1 2026, forming Ortho Tech by combining orthopaedic instruments with Mako and enabling technologies to simplify customer experience.
Following the change, Stryker will report two segments: MedSurg and Neurotechnology, and Orthopaedics; historical segment data has been recast.
Filing of this Form 8-K recasts consolidated financial statements for the three years ended Dec 31, 2025; recast does not restate audited financials.
Recast details are presented in Exhibit 99.1 and affect Notes 1, 2 and 14; Note 8 (goodwill/intangibles) was not recast but related amounts disclosed in Q1 2026 10-Q.
The reorganization aims to increase speed to market and focused innovation by aligning Mako, power tools, cutting accessories and enabling-technology teams.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.